StemSynergy Therapeutics competitorsClear all

StemSynergy Therapeutics's top competitors include Tiltan Pharma, Cantargia, NeOnc Technologies and Immutep.
StemSynergy Therapeutics
StemSynergy Therapeutics
StemSynergy Therapeutics (SSTI) is a biotechnology company focused on discovering drugs that target biomolecules and cellular processes fundamental to cancer.
Tiltan Pharma
Tiltan Pharma
Tiltan Pharma is a clinical stage biotechnology company focused on the development of novel and synergistic combinations of known drugs for the treatment of cancer.
Cantargia
Cantargia
Cantargia is a biotechnology company that specializes in the development of pharmaceuticals for various types of cancer, autoimmune and inflammatory diseases.
NeOnc Technologies
NeOnc Technologies
NeOnc Technologies is an early-stage cancer biotechnology company focused on intranasal inhalation of monoterpene.
Immutep
Immutep
Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.
Founding Date
Founding Date
N/A
Founding Date
2006
Founding Date
2010
Founding Date
2008
Founding Date
2001
Type
Type
Private
Type
Private
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Miami, US HQ
Franklin, US
Locations
Jerusalem, IL HQ
Locations
Lund, SE HQ
Locations
West Hollywood, US HQ
Locations
Sydney, AU HQ
Sydney, AU
Orsay, FR
Berlin, DE
Leipzig, DE
Employees
Employees
9
Employees
2
Employees
843% decrease
Employees
N/A
Employees
2427% decrease
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
4
Twitter followers
1.6 k
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
297402
Alexa Website Rank
355077
Alexa Website Rank
145534

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 1.5m (almost 7 years ago)
Latest funding round
N/A
Latest funding round
$ 150k (over 8 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
$ 1.5m
Total funding raised
$ 1m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Tiltan Pharma
HQ
Jerusalem, IL
Employees
2

Tiltan Pharma is a clinical stage biotechnology company focused on the development of novel and synergistic combinations of known drugs for the treatment of cancer.

View company
Cantargia
HQ
Lund, SE
Employees
8↓ 43% decrease

Cantargia is a biotechnology company that specializes in the development of pharmaceuticals for various types of cancer, autoimmune and inflammatory diseases.

View company
NeOnc Technologies
HQ
West Hollywood, US

NeOnc Technologies is an early-stage cancer biotechnology company focused on intranasal inhalation of monoterpene.

View company
Immutep
HQ
Sydney, AU
Employees
24↓ 27% decrease

Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.

View company